Your job adverts can either attract or repel your ideal candidates and are arguably the most important element of your ...

Certification Underscores Sightview Software's High Standards in Healthcare Data SecurityRALEIGH, NC / ACCESSWIRE / September 19, 2024 / Sightview Software, a leading software provider for eye care ...

National survey of women across healthcare professions provides a road map for employers on policies and practices that women say are needed to improve equality.NEW YORK, NY / ACCESSWIRE / September ...

Stryker (NYSE: SYK) announced that it has completed the previously announced acquisition of care.ai, a privately held company ...

Health's New App Harnesses Innovation, Data and Technology to Deliver Affordable, Easy-to-Use Healthcare Solutions for Part-Time WorkersDUBUQUE, IA / ACCESSWIRE / September 19, 2024 / ful. Health is ...

REDWOOD CITY, CA / ACCESSWIRE / September 19, 2024 / Biotricity Inc. (OTCQB:BTCY), a leading Technology-as-a-Service (TaaS) company that is redefining the healthcare industry with cutting edge remote ...

As a vetted Alzheimer's Moonshot Community member, NeuroEM has collaborative access to a network of organizations contributing science and resources toward finding a cure for Alzheimer's disease.

Surgical Pain SAN DIEGO, CA / ACCESSWIRE / September 19, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative ...

This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix ...

New pharma agreement for Parsortix CTC analysisGUILDFORD, SURREY / ACCESSWIRE / September 19, 2024 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating ...

Half Year Results/Interim Report19-Sep-2024 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Zurich, 19th ...

SEATTLE, WA / ACCESSWIRE / September 18, 2024 / Aptevo Therapeutics Inc. (Nasdaq:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its ...